ArticleJournal of pathology and translational medicine2016

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma.

Gilhyang Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.